Companies: 10,795·Total market cap: $144.5T
Labcorp Holdings Inc.

Labcorp Holdings Inc.

LHNYSEHealthcare● Active
$263.83
$-1.32(-0.50%)
Market Cap$21.6B
P/E Ratio—
52W High$293.72
52W Low$241.81
Cash on HandFinancialsRevenue

Labcorp Holdings Inc. (LH) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

LH · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$532.3M▼ -65.0% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$532.3M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-65.0%
vs prior fiscal year
Latest Quarter
$981.1M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$532.3MCash on Hand
Total Debt$7.20BTotal Debt
Net Cash / Net Debt−$6.67BNet Debt Position
Cash vs Debt Ratio
Cash 7%Debt 93%

Labcorp Holdings Inc. carries a net debt position of $6.67B. Total debt ($7.20B) exceeds cash on hand ($532.3M). Labcorp Holdings Inc. cash vs debt ratio: 7% cash / 93% debt.

Net Cash = Cash & ST Investments − Total Debt$532.3M − $7.20B = −$6.67B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
LH annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$532.3M-65.0%
Dec 31, 2024$1.52B+182.9%
Dec 31, 2023$536.8M+67.4%
Dec 31, 2022$320.6M-78.2%
Dec 31, 2021$1.47B+11.5%
LH cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Labcorp Holdings Inc.
Labcorp Holdings Inc.YOU
LH
$532.3M2.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Labcorp Holdings Inc. (LH) cash on hand as of December 31, 2025 is $532.3M, comprising $532.3M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Labcorp Holdings Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Labcorp Holdings Inc. cash reserves or cash position.

Labcorp Holdings Inc. annual cash on hand history shows decreased -65.0% in 2025: decreased -65.0% in 2025. Labcorp Holdings Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Labcorp Holdings Inc. carries total debt of $7.20B against cash of $532.3M, resulting in a net debt position of -$6.67B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

LH cash on hand · 5 questions

As of December 31, 2025, Labcorp Holdings Inc. (LH) has $532,299,999 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $532,299,999 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $981,100,000. Data sourced from the annual 10-K filing via FMP.

LH cash on handLH cash reservesLH cash 2025how much cash does LH have

▸ Source: FMP /balance-sheet-statement · US GAAP · Labcorp Holdings Inc. · Labcorp Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025